Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Barr Pharmaceuticals Inc. forecast a full-year profit mostly above Wall Street estimates Thursday, and its 2008 revenue outlook is also slightly above analyst expectations.
| BRL | 65.8 |  -1.19 |
After reporting its third-quarter results, Barr narrowed its profit guidance to a range of $2.85 to $2.95 per share, from $2.70 to $3.05 per share. The revenue forecast was confirmed at $2.8 billion, while Barr had earlier expected $2.7 billion to $2.8 billion.
Analysts expect $2.86 per share on $2.76 billion in revenue, according to a Thomson Financial average.
Barr's adjusted third-quarter profit and revenue above Wall Street estimates, and Barr shares rose 44 cents to $62.76 in morning trading.
You've heard the talk of "Green" throughout the whole of 2008, bu...
Lenovo, with its IdeaPad line series is previewing Y-Series IdeaPad Y650 laptops at CES in Las Vegas together with other new Ideapad Y-series.
With oil prices rising over the past few years, many people want to know about the impact on spending and investment by oil companies. Though pri...
Cisco will unveil new consumer products and initiatives during apress conference at the 2009 ...
Building your business and corporate credit for your small business.
Get your next web design project done with our los angeles web design team - Best web design with great price.
Buy Real Estate, Tax Liens, and more- Fund your business or franchise without debt
Partners   
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
